Our results indicate that routine administration of G-CSF given from day +7 onward to patients receiving auto-SCT for myeloma results in faster engraftment than a deferred dose schedule, and also shortens the duration of severe neutropenia. The gene discussed is CSF3; the disease is Decreased total neutrophil count.